Blog

Renewable energy stocks sank Thursday morning, and for a variety of reasons.

As of 10:45 a.m. ET, shares of charging network operators Blink Charging (NASDAQ: BLNK) and ChargePoint (NYSE: CHPT) are

While a recession in 2023 is far from a foregone conclusion, the possibility of a mild economic pullback at some point this year is a key concern for investors. Fortunately, equities that pay out

With 2022 behind us, it's a great time to review the year's winners and losers. Regarding the winners, it's tempting to assume that, because a stock outperformed meaningfully last year, it's likely

The stock market hasn't performed well over the past year, and cannabis stocks have been in the crosshairs for bearish investors. The pain has been widespread across the marijuana industry, with the

Electric heavy truck maker Nikola (NASDAQ: NKLA) announced a new offering for its customers yesterday, but investors are still in a "show me" mode with the start-up as other early-stage electric

Shares of the consumer digital bank and payments company Discover Financial Services (NYSE: DFS) traded as much as 7.7% lower earlier this morning before paring some of those losses. As of 10:34

The past year has been a disappointing one for Nvidia (NASDAQ: NVDA) investors. Shares of the once high-flying chipmaker have fallen off a cliff and lost 33% of their value over the past 12 months

The healthcare sector spans a number of intriguing areas for investors. These include pharmaceuticals, health insurance, and medical devices. Within that last group sits AngioDynamics (NASDAQ: ANGO)

The success of Starbucks (NASDAQ: SBUX) has led to competitors emerging in the form of independents and smaller chains. One of these emerging names is BRC (NYSE: BRCC), otherwise known as Black

CRISPR Therapeutics' (NASDAQ: CRSP) gene-editing technologies use the Cas9 enzyme as a mechanism for cutting a targeted piece out of DNA -- with the aim of treating serious illnesses and conditions

It's a bit soon to simply declare the bear market over, but things clearly aren't quite as ugly as investors recently feared. Companies remain in the black, inflation is cooling, and jobs are still

Beating the markets doesn't have to mean spending hours to find an up-and-coming growth stock that no one knows. You don't have to try and look for the next Microsoft or Alphabet. Large, stable

On Jan. 3, 2022, Apple's (NASDAQ: AAPL) stock reached an all-time high of $180.73 after a nearly two-year period where the tech industry flourished. Pandemic closures throughout 2020 and 2021 led

At this point, the "death of retail" is a well-hewn storyline in the market. Down about 75% over the past decade, Chico's FAS (NYSE: CHS) looks like it's unfortunately another name in this

DocuSign (NASDAQ: DOCU) was once a red-hot growth stock. The e-signature services leader went public at $29 per share in April 2018, and its shares closed at a record high of $310.05 in September

Salesforce (NYSE: CRM) stock reacted to the Federal Reserve raising interest rates the same as most technology companies -- its share price fell 34% over the last year. Worse, the slowing economy is

The crypto market is still as volatile as a box of firecrackers. That's no secret. Global blockchain ledgers of digital coins and tokens are still new, especially in the investing arena.

I'm

Those who hoped that 2023 would be a nice straight-up recovery from last year's bear market felt disappointed Thursday morning, as Wall Street saw stock market indexes give up some more ground after

With no immediate hope of federal decriminalization or even the SAFE Banking Act being passed, it may be awhile until the market looks favorably toward cannabis stocks. In the meantime, investors

In June 2021, shares of Biogen (NASDAQ: BIIB) soared to more than $400 after the Food and Drug Administration (FDA) granted accelerated approval to its Alzheimer's treatment Aduhelm. There wasn't

Chewy (NYSE: CHWY) is well-known in the pet supply world but a relatively tiny player in the broader retailing industry. It hasn't yet cracked $10 billion in annual sales, after all.

But many

Marijuana stocks had a difficult year. With the broader market falling, cannabis stocks took a bigger hit in 2022 due to the lack of progress toward federal legalization in the U.S.

But there is

Hedge fund managers Jim Simons of Renaissance Technologies and Jason Kritzer of Eaton Vance Management have helped their funds outperform the S&P 500 over the last three years. That may not sound

Last year wasn't a great year for Nasdaq stocks. In fact, the Nasdaq 100 had its worst year since 2008, logging an annual total return of negative 32% in 2022. Yet some stocks performed far worse

Buying stocks is easier than ever, but that also means it's easier to make rash, quick investing decisions that could impact your portfolio and your financial position. Investors should look to